No COVID-19 vaccine for kids under 5 is going to be available this month after all.
Pfizer announced on Friday that it will continue to "wait for the three-dose data" from its COVID-19 vaccine trial in kids 6 months to 5 years of age, before submitting for an Emergency Use Authorization with the US Food and Drug Administration this spring.
"Given that the study is advancing at a rapid pace, the companies will wait for the three-dose data as Pfizer and BioNTech continue to believe it may provide a higher level of protection in this age group," the pharmaceutical company said in a release. "The companies expect to have three-dose protection data available in early April."
Read More (...)